Show simple item record

dc.contributor.authorMacFarlane, I A
dc.contributor.authorBarnes, D
dc.contributor.authorHowat, J M
dc.contributor.authorSwindell, Ric
dc.contributor.authorDurning, P
dc.contributor.authorBeardwell, Colin G
dc.contributor.authorBush, H
dc.contributor.authorSellwood, R A
dc.date.accessioned2011-12-22T12:27:53Z
dc.date.available2011-12-22T12:27:53Z
dc.date.issued1980-11
dc.identifier.citationSerum glycoprotein hormone alpha subunit, hormone receptors and disease stage in patients with breast cancer. 1980, 42 (5):645-50 Br. J. Canceren
dc.identifier.issn0007-0920
dc.identifier.pmid6161628
dc.identifier.urihttp://hdl.handle.net/10541/198682
dc.description.abstractThe concentration of the common alpha subunit of the glycoprotein hormones was high in the serum of 21/56 (38%) of premenopausal patients and 22/106 (21%) of postmenopausal patients with primary breast cancer, at the time of presentation. 7/59 (12%) of patients with benign disease also had high alpha subunit levels. Tumour cytosol oestrogen and progesterone receptor status was determined in 80% of the patients with cancer, and there was a trend towards higher alpha levels in patients without receptors, but this was not statistically significant. In the premenopausal patients with cancer there was a significant correlation between alpha subunit level and disease stage, R = 0.47, P = 0.0001, but not in the postmenopausal patients. In view of the correlation with disease stage, high levels of alpha subunit in premenopausal patients with breast cancer at presentation with the primary tumour may indicate poor prognosis.
dc.language.isoenen
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshBreast Neoplasms
dc.subject.meshChorionic Gonadotropin
dc.subject.meshFemale
dc.subject.meshFollicle Stimulating Hormone
dc.subject.meshGlycoprotein Hormones, alpha Subunit
dc.subject.meshHumans
dc.subject.meshLuteinizing Hormone
dc.subject.meshMenopause
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasm Staging
dc.subject.meshPeptide Fragments
dc.subject.meshReceptors, Cell Surface
dc.subject.meshThyrotropin
dc.titleSerum glycoprotein hormone alpha subunit, hormone receptors and disease stage in patients with breast cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Endocrinology, Christie Hospital, Manchester, UK.en
dc.identifier.journalBritish Journal of Canceren
dc.identifier.pmcidPMC2010551
html.description.abstractThe concentration of the common alpha subunit of the glycoprotein hormones was high in the serum of 21/56 (38%) of premenopausal patients and 22/106 (21%) of postmenopausal patients with primary breast cancer, at the time of presentation. 7/59 (12%) of patients with benign disease also had high alpha subunit levels. Tumour cytosol oestrogen and progesterone receptor status was determined in 80% of the patients with cancer, and there was a trend towards higher alpha levels in patients without receptors, but this was not statistically significant. In the premenopausal patients with cancer there was a significant correlation between alpha subunit level and disease stage, R = 0.47, P = 0.0001, but not in the postmenopausal patients. In view of the correlation with disease stage, high levels of alpha subunit in premenopausal patients with breast cancer at presentation with the primary tumour may indicate poor prognosis.


This item appears in the following Collection(s)

Show simple item record